JSM2023
Back to all people

Bethany Gill

AstraZeneca
1 appearance in the program

Sessions & presentations

Use and Challenges with surrogate, composite endpoints and Generalized pairwise comparisons for accelerating drug development
Presentation: The use of surrogate endpoints to manage the risk and accelerate drug development in oncology
Topic-Contributed Paper Session · Thu, Aug 10 , 10:30 AM
Speaker
↑